揭露SARS-CoV-2的凝血阴谋:斯派克的作用
Tom Aschman1, Helena Radbruch1
1Institut für Neuropathologie, Charité Universitätsmedizin Berlin, Berlin, Germany.
Trends in immunology
|September 27, 2024
概括
SARS-CoV-2 尖端蛋白与纤维素相互作用,影响小鼠的血液凝结和自然杀手 (NK) 细胞免疫反应. 这种相互作用表明了COVID-19治疗的潜在新疗法策略.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 血液学 血液学 血液学
背景情况:
- 导致COVID-19的SARS-CoV-2病毒与宿主免疫系统有复杂的相互作用.
- 在严重的COVID-19病例中经常观察到凝血异常.
- 自然杀手 (NK) 细胞在抗病毒免疫力中起着至关重要的作用.
研究的目的:
- 为了研究SARS-CoV-2尖刺蛋白与纤维素原的结合.
- 阐明这种相互作用对凝血和NK细胞反应的影响.
- 基于这些发现,探索COVID-19的潜在治疗点.
主要方法:
- 在体外测试以评估Spike蛋白与纤维素原结合.
- 用小鼠模型进行研究,以评估对凝血参数的影响.
- 在Spike蛋白和纤维素原的存在下分析NK细胞活动和功能.
主要成果:
- 证明了SARS-CoV-2尖端蛋白和纤维素原之间的直接结合.
- 在小鼠暴露于Spike蛋白后观察到凝血通路的变化.
- 报告了对NK细胞反应的显著影响,包括细胞毒性和细胞因子生产的变化.
结论:
- SARS-CoV-2 Spike 蛋白与纤维素素的相互作用影响了凝血和NK 细胞介导免疫.
- 这种互动为针对COVID-19的治疗干预提供了一个新的目标.
- 需要进一步的研究来将这些发现转化为临床应用.
更多相关视频
08:40Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
58.9K
07:53A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
Published on: January 9, 2019
33.1K
相关概念视频
Coagulation
5.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.4K
Extrinsic and Intrinsic Pathways of Hemostasis
6.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.3K
Formation of the Platelet Plug
5.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
636
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
636
Introduction to Hemostasis
6.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.4K
Clot Retraction and Fibrinolysis
4.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.7K
